OUR PRACTICES TO ACHIEVE THE SDGs

OUR PRACTICES TO ACHIEVE
THE SDGs

In order to undertake and practice to the Global Compact, we set our priority goals from the Sustainable Development Goals (SDGs). Through the priority goals, we strive to solve a wide range of issues relevant to the company, such as global poverty, health, education, climate change, environmental degradation.

PRIORITY

We comply with relevant laws and respect international standards, then prioritize the issues, clarify the goals, and work on the sustainable SDGs.

SDGs activity report 2023
Sustainability Report 2024Note: Only Japanese-language reports were prepared.

Social contributions through core business

Goal 3
Through our contract manufacturing business of active pharmaceutical ingredients, we manufacture high-quality pharmaceuticals under cGMP control and contribute to the health of people around the world through stable supply.

Promote energy conservation

Goal 7
・Reduce energy consumption based on energy intensity.
・Promote the introduction of low-GHG (green-house gas) equipments and devices.

Respect for human rights and compliance with laws and regulations through business activities

Goal 8
・Achieve revitalization of the organization by promoting work style reforms.
・Use in-company human resources efficiently and systematically recruit employees, looking ahead to the future.
・Strengthen the CSR procurement throughout the supply chain.

Technological Development to Contribute to Pharmaceutical Manufacturing APIs

Goal 9
The modalities of pharmaceuticals are evolving in a wide range of variations. Our company aims to develop technologies that contribute not just to the small molecule drugs in which we are experts but also other therapeutic modalities such as nucleic acid and mRNA.
ABOUT NUCLEOTIDES

Risk management, promotion of crisis management, reduction of raw material consumption, enhancement of recycling, development of environmentally friendly manufacturing methods

Goal 12
・Reduce energy consumption by promoting the stable procurement of raw materials and conducting the planned production.
・Reduce usage of harmful substances and strengthen the management of harmful substances in products.
・Promote recycling of organic solvents.
・Promote reduction of processes and raw materials by improvement of manufacturing methods.

Industrial wastewater management

Goal 14
・Complete management of the facilities of activated sludge process, Achieve the regulated value of treated wastewater for release to the Osaka Bay.
・Complete wastewater management for sewage.
・Complete control of the processing method of industrial waste generated from the facilities for high potency active pharmaceutical ingredient.

BACK NUMBER

2019（fiscal year） NON-FINANCIAL INFORMATION
ENVIROMENT DATA
SDGs ACTIVITY REPORT
2020（fiscal year） NON-FINANCIAL INFORMATION
ENVIROMENT DATA
ENVIRONMENTALLY COMPATIBLE PRODUCTS
SDGs ACTIVITY REPORT
2021（fiscal year） NON-FINANCIAL INFORMATION
ENVIROMENT DATA
ENVIRONMENTALLY COMPATIBLE PRODUCTS
SDGs ACTIVITY REPORT
GHG emissions
2022（fiscal year） NON-FINANCIAL INFORMATION
ENVIROMENT DATA
ENVIRONMENTALLY COMPATIBLE PRODUCTS
SDGs ACTIVITY REPORT
GHG emissions
2019（fiscal year）
NON-FINANCIAL INFORMATION
ENVIROMENT DATA
SDGs ACTIVITY REPORT
2020（fiscal year）
NON-FINANCIAL INFORMATION
ENVIROMENT DATA
ENVIRONMENTALLY COMPATIBLE PRODUCTS
SDGs ACTIVITY REPORT
2021（fiscal year）
NON-FINANCIAL INFORMATION
ENVIROMENT DATA
ENVIRONMENTALLY COMPATIBLE PRODUCTS
SDGs ACTIVITY REPORT
GHG emissions
2022（fiscal year）
NON-FINANCIAL INFORMATION
ENVIROMENT DATA
ENVIRONMENTALLY COMPATIBLE PRODUCTS
SDGs ACTIVITY REPORT
GHG emissions

OUR INITIATIVE

CONTACT